X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
GLENMARK PHARMACEUTICALS LIMITED Fact Sheet - Equitymaster
Investing in India? Get Equitymaster Research  

GLENMARK PHARMACEUTICALS LIMITED  (GLPH)


Here is the latest financial fact sheet of Glenmark Pharma. For more details, see the Glenmark Pharma quarterly results and Glenmark Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.
 
glenmark pharma - 1 Year Stock Price Chart
Loading...

 Price History
    Price Rs 892.9       No. of shares m 271.28
    Mkt Cap Rs m 242,212       % ch % 1.0
    Vol '000 37.6       % ch week % -0.6
    P/E X 22.0       % ch 1-mth % -4.4
    P/CF X 24.9       % ch 12-mth % 8.6
    EPS (TTM) Rs 40.5       52 week H/L Rs 993.0/729.3
(As on Mar 23, 2017 (Close)) »  Best Performing pharmaceuticals Stocks

Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!
 Financials

* Results Consolidated
No. of Months
Year Ending
12
Mar-12
*
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
5-Yr Chart
Click to enlarge
  EQUITY SHARE DATA
High Rs3515516128791,262 
Low Rs263301464752672 
Sales per share (Unadj.) Rs148.6185.1221.4244.4270.6 
Earnings per share (Unadj.) Rs17.223.220.117.524.9 
Diluted earnings per shareRs17.123.220.117.525.9 
Cash flow per share (Unadj.) Rs20.827.928.127.134.4 
Dividends per share (Unadj.) Rs2.002.002.002.002.00 
Adj. dividends per shareRs1.992.002.002.002.08 
Dividend yield (eoy) %0.70.50.40.20.2 
Book value per share (Unadj.) Rs88.8102.0110.0110.6151.3 
Adj. book value per shareRs88.5101.9110.0110.6157.4 
Shares outstanding (eoy) m270.53270.85271.22271.29282.16 
Bonus/Rights/Conversions  ESOS---- 
Price / Sales ratio x2.12.32.43.33.6 
Avg P/E ratio x17.918.426.746.638.9 
P/CF ratio (eoy) x14.815.319.130.128.1 
Price / Book Value ratio x3.54.24.97.46.4 
Dividend payout %11.78.69.911.48.0 
Avg Mkt Cap Rs m83,053115,355145,889221,284272,778 
No. of employees `000NANANA9.510.0 
Total wages/salary Rs m6,2897,83010,26212,02413,782 
Avg. sales/employee Rs ThNMNMNM6,961.17,614.9 
Avg. wages/employee Rs ThNMNMNM1,262.51,374.8 
Avg. net profit/employee Rs ThNMNMNM499.0700.2 
  INCOME DATA
Net Sales Rs m40,20650,12360,05266,29876,340 
Other income Rs m182108115219356 
Total revenues Rs m40,38850,23160,16766,51676,696 
Gross profit Rs m7,14410,15310,90810,22514,172 
Depreciation Rs m9791,2702,1682,6002,691 
Interest Rs m1,4661,6001,8861,9021,789 
Profit before tax Rs m4,8817,3906,9695,94310,048 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m2381,1071,5131,1903,028 
Profit after tax Rs m4,6436,2835,4564,7527,019 
Gross profit margin %17.820.318.215.418.6 
Effective tax rate %4.915.021.720.030.1 
Net profit margin %11.512.59.17.29.2 
  BALANCE SHEET DATA
Current assets Rs m29,47237,26847,62753,23359,096 
Current liabilities Rs m19,01722,01429,49237,11340,018 
Net working cap to sales %26.030.430.224.325.0 
Current ratio x1.51.71.61.41.5 
Inventory Days Days7261577075 
Debtors Days Days113119131138119 
Net fixed assets Rs m24,24827,68230,35732,70439,075 
Share capital Rs m271271271271282 
"Free" reserves Rs m15,78919,33821,41517,56330,281 
Net worth Rs m24,01627,63029,83330,00342,703 
Long term debt Rs m13,12519,20324,28725,74424,873 
Total assets Rs m54,66071,71086,33696,875111,026 
Interest coverage x4.35.64.74.16.6 
Debt to equity ratio x0.50.70.80.90.6 
Sales to assets ratio x0.70.70.70.70.7 
Return on assets %11.211.08.56.97.9 
Return on equity %19.322.718.315.816.4 
Return on capital %17.119.216.414.117.5 
Exports to sales %13.411.911.744.843.3 
Imports to sales %0.91.71.07.17.4 
Exports (fob) Rs m5,4065,9577,03929,72033,044 
Imports (cif) Rs m3478585794,6805,672 
Fx inflow Rs m5,6627,0078,52831,29936,945 
Fx outflow Rs m2,3644,1353,64110,85661,066 
Net fx Rs m3,2982,8724,88820,443-24,122 
  CASH FLOW
From Operations Rs m 8,044 6,479 8,537 4,817 3,449 
From Investments Rs m -2,778 -4,641 -3,681 -5,400 -8,802 
From Financial Activity Rs m -3,614 1,952 -980 1,992 6,986 
Net Cashflow Rs m 1,252 2,851 1,896 -311 934 
* Results Consolidated Source: Company Annual Reports, Regulatory Filings, Equitymaster »  Historical quarterly results for glenmark pharmaceuticals limited

 Share Holding
Indian Promoters : 48.3%
Foreign collaborators : 0.0%
Indian inst/Mut Fund : 6.9%
FIIs : 34.4%
ADR/GDR : 0.0%
Free float : 10.5%
Shareholders : 56,727
Pledged promoter(s) holding : 0.0%
 Company Information
Top
    REGD OFF: B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai - 400 026
    E-MAIL: complianceofficer@glenmarkpharma.com     WEB: www.glenmarkpharma.com
    TELEPHONE: (022) 4018 9999     FAX: (022) 4018 9986
    SECTOR: PHARMACEUTICALS     GROUP: MISCELLANEOUS
    TR AGENT: Karvy Computer, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
    AUDITOR: Walker, Chandiok & Co.
CHM: Glenn Saldanha (MD) COMP SEC: Sanjay Kumar Chowdhary YEAR OF INC: 1977 BSE CODE: 532296 FV (Rs): 1 DIV YIELD (%): 0.2

More pharmaceuticals Company Fact Sheets:   ELDER PHARMADISHMAN PHARMAAJANTA PHARMAINDRAPRASTHA MEDICALDIVIS LABORATORIES


Today's Market

Sensex Closes Firm; NTPC Surges 2.3%(Closing)

Indian share markets continued to trade higher owing to firm global cues with energy stocks leading the gains, while financial stocks and auto stocks bounced back.

Views on news

Glenmark: Zetia Generics Boost Growth (Quarterly Results Update - Detailed)

Feb 15, 2017

Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.

Glenmark: High Costs hit the Bottom line (Quarterly Results Update - Detailed)

Nov 8, 2016

Glenmark has announced its 2QFY16 results. The company has reported 15.7% YoY growth in net sales and 3.5% YoY increase in net profits. Here is our analysis of the results.

Glenmark: Other Income Boosts Profit Growth (Quarterly Results Update - Detailed)

Sep 6, 2016

Glenmark has announced its 1QFY17 results. The company has reported 15.8% YoY growth in net sales and 24% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

More Views on News

Most Popular

Bluechips Have 60% Chance Of Losing Money At Current Levels. But a Small Group Won't...(The 5 Minute Wrapup)

Mar 17, 2017

The trend that makes a select group of bluechip stocks inherently safer even at peak index valuations.

As Digital Transactions Fall, Indians Are Going Back to Cash(Vivek Kaul's Diary)

Mar 16, 2017

Digital transactions have fallen since December 2016 both in value and volume terms.

Stock Markets and Gold Rally, Dollar Tumbles(Chart Of The Day)

Mar 16, 2017

Markets are moving up even after the fed interest rate hike.

Doubled Your Money In D-Mart? Read This Before It's Too Late(Daily Profit Hunter)

Mar 22, 2017

Apurva breaks down the historic performance of initial public offerings in the context of D-Mart.

4 Things To Watch Out For After Modi's Landslide Win In UP Polls(Outside View)

Mar 15, 2017

PersonalFN explains why you need to wary while investing in equities despite Modi's UP win.

More

TRACK GLENMARK PHARMA

  • Track your investment in GLENMARK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GLENMARK PHARMA

GLENMARK PHARMA - TEVA PHARMA COMPARISON

Compare Company With Charts

COMPARE GLENMARK PHARMA WITH

MARKET STATS